- Home
- SMTI vs OPP Comparison
SMTI vs OPP Comparison
Compare SMTI & OPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTI
- OPP
- Stock Information
- Founded
- SMTI 1982
- OPP 2010
- Country
- SMTI United States
- OPP United States
- Employees
- SMTI 141
- OPP N/A
- Industry
- SMTI Medical/Dental Instruments
- OPP Finance/Investors Services
- Sector
- SMTI Health Care
- OPP Finance
- Exchange
- SMTI Nasdaq
- OPP Nasdaq
- Market Cap
- SMTI 251.6M
- OPP 204.0M
- IPO Year
- SMTI N/A
- OPP N/A
- Fundamental
- Price
- SMTI $29.25
- OPP $8.34
- Analyst Decision
- SMTI Strong Buy
- OPP
- Analyst Count
- SMTI 2
- OPP 0
- Target Price
- SMTI $50.00
- OPP N/A
- AVG Volume (30 Days)
- SMTI 22.8K
- OPP 108.0K
- Earning Date
- SMTI 11-12-2025
- OPP 01-01-0001
- Dividend Yield
- SMTI N/A
- OPP 14.41%
- EPS Growth
- SMTI N/A
- OPP N/A
- EPS
- SMTI N/A
- OPP N/A
- Revenue
- SMTI $97,241,894.00
- OPP N/A
- Revenue This Year
- SMTI $24.49
- OPP N/A
- Revenue Next Year
- SMTI $14.43
- OPP N/A
- P/E Ratio
- SMTI N/A
- OPP N/A
- Revenue Growth
- SMTI 34.29
- OPP N/A
- 52 Week Low
- SMTI $23.53
- OPP $7.26
- 52 Week High
- SMTI $39.08
- OPP $8.83
- Technical
- Relative Strength Index (RSI)
- SMTI 44.28
- OPP 34.91
- Support Level
- SMTI $28.00
- OPP $8.22
- Resistance Level
- SMTI $30.99
- OPP $8.42
- Average True Range (ATR)
- SMTI 1.35
- OPP 0.11
- MACD
- SMTI -0.29
- OPP -0.02
- Stochastic Oscillator
- SMTI 24.86
- OPP 23.97
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
About OPP RiverNorth/DoubleLine Strategic Opportunity Fund Inc.
RiverNorth/DoubleLine Strategic Opportunity Fund Inc is a closed-end management investment company. The company's investment objective is to seek current income and overall total return.